(AMSF) AMERISAFE - Overview
Sector: Financial Services | Industry: Insurance - Specialty | Exchange: NASDAQ (USA) | Market Cap: 581m USD | Total Return: -31.7% in 12m
Avg Turnover: 6.17M
EPS Trend: -99.2%
Qual. Beats: -2
Rev. Trend: 57.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
AMERISAFE, Inc. (AMSF) is a specialty provider of workers compensation insurance focused on hazardous industries within the United States. The company serves small to mid-sized employers in high-risk sectors such as construction, trucking, logging, manufacturing, and maritime operations. Its policies cover statutory benefits for injured workers, including medical expenses, disability payments, and death benefits.
Operating within the Property & Casualty insurance sector, AMERISAFE focuses on niche underwriting where specialized safety knowledge and loss control are critical to maintaining profitability. Unlike broad-market insurers, high-hazard specialists often benefit from lower competition due to the technical expertise required to price risks in dangerous work environments. The company utilizes a distribution network of independent retail and wholesale brokers to reach its target client base.
Investors can evaluate the companys historical performance and valuation metrics on ValueRay. Founded in 1985 and headquartered in Louisiana, AMERISAFE maintains a focused business model centered on high-exposure employment classes.
- Loss ratio stability in high-hazard industries dictates quarterly underwriting profitability
- Payroll growth in construction and trucking sectors drives direct premium volume
- Investment income sensitivity to prevailing interest rate environments impacts net earnings
- Competitive pricing pressure in workers compensation markets affects policy renewal rates
- Regulatory shifts in state-mandated insurance rates influence long-term top-line growth
| Net Income: 46.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.71 > 1.0 |
| NWC/Revenue: -108.2% < 20% (prev -194.9%; Δ 86.71% < -1%) |
| CFO/TA 0.01 > 3% & CFO 10.2m > Net Income 46.3m |
| Net Debt (-122.8m) to EBITDA (58.5m): -2.10 < 3 |
| Current Ratio: 0.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.9m) vs 12m ago -1.52% < -2% |
| Gross Margin: 47.60% > 18% (prev 0.42%; Δ 4.72k% > 0.5%) |
| Asset Turnover: 30.00% > 50% (prev 28.90%; Δ 1.10% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: -0.31 (Total Current Assets 412.2m - Total Current Liabilities 763.5m) / Total Assets 1.12b |
| B: 0.07 (Retained Earnings 83.3m / Total Assets 1.12b) |
| C: 0.05 (EBIT TTM 57.8m / Avg Total Assets 1.08b) |
| D: 0.09 (Book Value of Equity 77.8m / Total Liabilities 876.4m) |
| Altman-Z'' = -1.36 = CCC |
| DSRI: 1.71 (Receivables 288.4m/156.7m, Revenue 324.8m/301.2m) |
| GMI: 0.88 (GM 47.60% / 41.89%) |
| AQI: 0.78 (AQ_t 0.63 / AQ_t-1 0.80) |
| SGI: 1.08 (Revenue 324.8m / 301.2m) |
| TATA: 0.03 (NI 46.3m - CFO 10.2m) / TA 1.12b) |
| Beneish M = -2.59 (Cap -4..+1) = A |
As of May 28, 2026, the stock is trading at USD 30.85 with a total of 185,710 shares traded.
Over the past week, the price has changed by -1.63%,
over one month by +0.36%,
over three months by -3.97% and
over the past year by -31.67%.
AMERISAFE has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold AMSF.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36.7 | 18.9% |
P/E Trailing = 12.7778
P/E Forward = 22.3714
P/S = 1.7881
P/B = 2.374
P/EG = 1.8102
Revenue TTM = 324.8m USD
EBIT TTM = 57.8m USD
EBITDA TTM = 58.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.03m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 536k
Net Debt = -122.8m USD (calculated: Debt 1.03m - CCE 123.8m)
Enterprise Value = 458.0m USD (580.8m + Debt 1.03m - CCE 123.8m)
Interest Coverage Ratio = unknown (Ebit TTM 57.8m / Interest Expense TTM 0.0)
EV/FCF = 57.31x (Enterprise Value 458.0m / FCF TTM 7.99m)
FCF Yield = 1.75% (FCF TTM 7.99m / Enterprise Value 458.0m)
FCF Margin = 2.46% (FCF TTM 7.99m / Revenue TTM 324.8m)
Net Margin = 14.27% (Net Income TTM 46.3m / Revenue TTM 324.8m)
Gross Margin = 47.60% ((Revenue TTM 324.8m - Cost of Revenue TTM 170.2m) / Revenue TTM)
Gross Margin QoQ = 42.02% (prev 64.52%)
Tobins Q-Ratio = 0.41 (Enterprise Value 458.0m / Total Assets 1.12b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 1.03m)
Taxrate = 19.83% (2.02m / 10.2m)
NOPAT = 46.3m (EBIT 57.8m * (1 - 19.83%))
Current Ratio = 0.54 (Total Current Assets 412.2m / Total Current Liabilities 763.5m)
Debt / Equity = 0.00 (Debt 1.03m / totalStockholderEquity, last quarter 246.6m)
Debt / EBITDA = -2.10 (Net Debt -122.8m / EBITDA 58.5m)
Debt / FCF = -15.36 (Net Debt -122.8m / FCF TTM 7.99m)
Total Stockholder Equity = 259.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.28% (Net Income 46.3m / Total Assets 1.12b)
RoE = 17.85% (Net Income TTM 46.3m / Total Stockholder Equity 259.6m)
RoCE = 16.08% (EBIT 57.8m / Capital Employed (Total Assets 1.12b - Current Liab 763.5m))
RoIC = 13.41% (NOPAT 46.3m / Invested Capital 345.5m)
WACC = 5.77% (E(580.8m)/V(581.8m) * Re(5.78%) + D(1.03m)/V(581.8m) * Rd(0.0%) * (1-Tc(0.20)))
Discount Rate = 5.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -73.33 | Cagr: -0.83%
[DCF] Terminal Value 73.10% ; FCFF base≈10.7m ; Y1≈9.40m ; Y5≈7.59m
[DCF] Fair Price = 13.08 (EV 121.8m - Net Debt -122.8m = Equity 244.6m / Shares 18.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -99.21 | EPS CAGR: -12.82% | SUE: -0.98 | # QB: -2
Revenue Correlation: 57.57 | Revenue CAGR: 1.29% | SUE: 0.44 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.52 | Chg30d=-1.26% | Revisions=-33% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.53 | Chg30d=-2.15% | Revisions=-20% | Analysts=3
EPS current Year (2026-12-31): EPS=2.08 | Chg30d=-4.22% | Revisions=-33% | GrowthEPS=-4.9% | GrowthRev=+5.1%
EPS next Year (2027-12-31): EPS=2.08 | Chg30d=-6.37% | Revisions=-33% | GrowthEPS=+0.0% | GrowthRev=+5.6%
[Analyst] Revisions Ratio: -33%